Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This U2C Funding Opportunity Announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 2 diabetes research (SEIC-T2D). A primary goal of the SEIC-T2D is to accelerate equitable engagement of individuals from and communities of diverse backgrounds and sectors in developing the research priorities and activities that involve them, particularly underserved communities, and those with the highest proportion of diabetes-related morbidity and mortality. The SEIC-T2D will provide highly specialized research resources to support field investigators by fully embedding communities, patients, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T2D will also establish a network consisting of multidisciplinary research investigators, including from underrepresented groups, with expertise in T2D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T2D prevention and treatment.

Deadlines:

  • Letter of Intent Due Date(s): September 26, 2022

  • Application Due Date: October 26, 2022

RFA-DK-22-001 Expiration Date October 27, 2022

Agency Website

Amount

$9,500,000

Amount Description

Application budgets are limited to $1,900,000 in direct costs for each year, but need to reflect the actual needs of the proposed project.

The maximum project period is 5 years.

Funding Type

Grant

Eligibility

Faculty

Category

Community Outreach and Engagement
Interdisciplinary
Medical
Medical - Clinical Science
Medical - Translational

External Deadline

October 26, 2022